GTF2H2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.191600E-01
Normal-vs-Stage2
8.659000E-01
Normal-vs-Stage3
2.388200E-01
Normal-vs-Stage4
1.342820E-01
Stage1-vs-Stage2
6.234600E-01
Stage1-vs-Stage3
2.856800E-01
Stage1-vs-Stage4
5.586400E-01
Stage2-vs-Stage3
2.387400E-01
Stage2-vs-Stage4
2.041000E-01
Stage3-vs-Stage4
1.443590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.246400E-01
Normal-vs-AfricanAmerican
3.686400E-01
Normal-vs-Asian
6.766000E-01
Caucasian-vs-AfricanAmerican
2.743800E-01
Caucasian-vs-Asian
3.235400E-01
AfricanAmerican-vs-Asian
7.256100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.125400E-01
Normal-vs-Female
9.933600E-01
Male-vs-Female
1.072560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.718000E-01
Normal-vs-Age(41-60Yrs)
8.937600E-01
Normal-vs-Age(61-80Yrs)
8.129200E-01
Normal-vs-Age(81-100Yrs)
8.901400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.802600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.729400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.978200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.783800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.677200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.200400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.834400E-01
Normal-vs-Daily Drinker
8.578600E-01
Normal-vs-Weekly Drinker
7.380400E-01
Normal-vs-Occasional Drinker
6.648000E-01
Normal-vs-Social Drinker
6.929200E-01
Non Drinker-vs-Daily Drinker
7.373200E-01
Non Drinker-vs-Weekly Drinker
5.084200E-01
Non Drinker-vs-Occasional Drinker
2.738200E-01
Non Drinker-vs-Social Drinker
3.558400E-01
Daily Drinker-vs-Weekly Drinker
7.125200E-01
Daily Drinker-vs-Occasional Drinker
2.132200E-01
Daily Drinker-vs-Social Drinker
2.678000E-01
Weekly Drinker-vs-Occasional Drinker
2.011000E-01
Weekly Drinker-vs-Social Drinker
2.372800E-01
Occasional Drinker-vs-Social Drinker
8.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.247400E-01
Normal-vs-Grade 2
9.741200E-01
Normal-vs-Grade 3
7.687800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.841600E-01
Grade 1-vs-Grade 3
2.167800E-01
Grade 1-vs-Grade 4
9.247400E-01
Grade 2-vs-Grade 3
3.122200E-01
Grade 2-vs-Grade 4
9.741200E-01
Grade 3-vs-Grade 4
7.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.384400E-01
Normal-vs-NonDiabetic
8.853000E-01
Diabetic-vs-NonDiabetic
7.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.182200E-01
Normal-vs-NoPancreatitis
8.139400E-01
Pancreatitis-vs-NoPancreatitis
2.619400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.416600E-01
Normal-vs-N1
8.659200E-01
N0-vs-N1
4.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.986800E-01
Normal-vs-TP53-NonMutant
4.993200E-01
TP53-Mutant-vs-TP53-NonMutant
8.731800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
